I don't know what his lipids would have been otherwise, but I do know that at least 50% of first time MACE's are in people with normal lipids. We are learning that the MOA's for CVD prevention go well beyond lipid management. I recall the recently posted CAC score by PharmacyDude (who otherwise has normal lipids) is a good example of the fallibility of lipid testing. Besides, VASCEPA has many other pleotropic effects that don't show up on the label. Another point: The VASCEPA label doesn't call for "fasting" Trigs, so yes I'm ok with it.
I'm certainly in favor of it. Are you against anyone who wants do everything they can to reduce their CV health risks? Care to explain that? Based on all the anecdotal evidence that V has anti-inflammatory properties and has a proven safety profile. Why would you want to deny this person?
Pretty rich from the same guy kvetching over his insurability while free rock climbing, surfing, and skydiving. Maybe "doesn't need" is relative after all.
Market Data 
Markets 
AI
